Research Analysts’ Updated EPS Estimates for November 3rd (CERO, DNLM, FRAS, JAMF, PBEE, PNN, PRB, SGE, SNR, VOD)

Research Analysts’ updated eps estimates for Monday, November 3rd:

CERo Therapeutics (NASDAQ:CERO) had its hold rating reissued by analysts at Maxim Group.

Dunelm Group (LON:DNLM) was upgraded by analysts at Royal Bank Of Canada to an outperform rating. Royal Bank Of Canada currently has GBX 1,300 target price on the stock, up from their previous target price of GBX 1,200.

Frasers Group (LON:FRAS) was downgraded by analysts at Royal Bank Of Canada to a sector perform rating. The firm currently has GBX 800 target price on the stock, up from their previous target price of GBX 775.

Jamf (NASDAQ:JAMF) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. The firm currently has a $13.00 target price on the stock, up from their previous target price of $12.00.

PensionBee Group (LON:PBEE) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 170 price target on the stock.

Pennon Group (LON:PNN) was downgraded by analysts at Citigroup Inc. to a neutral rating. The firm currently has GBX 542 price target on the stock, up from their previous price target of GBX 539.

Probe Gold (CVE:PRB) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. The firm currently has C$3.65 price target on the stock, down from their previous price target of C$5.50.

The Sage Group (LON:SGE) was upgraded by analysts at Canaccord Genuity Group Inc. to a hold rating. Canaccord Genuity Group Inc. currently has GBX 1,100 target price on the stock, up from their previous target price of GBX 1,080.

Senior (LON:SNR) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 185 price target on the stock.

Vodafone Group Public (LON:VOD) was downgraded by analysts at UBS Group AG to a sell rating. The firm currently has GBX 80 price target on the stock, up from their previous price target of GBX 72.

Zegona Communications (LON:ZEG) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 1,500 price target on the stock.

Receive News & Ratings for CERo Therapeutics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.